DK4346847T3 - Pluri-ionisk kompleks til anvendelse i forebyggelse eller behandling af neurogen inflammation - Google Patents

Pluri-ionisk kompleks til anvendelse i forebyggelse eller behandling af neurogen inflammation

Info

Publication number
DK4346847T3
DK4346847T3 DK22732150.2T DK22732150T DK4346847T3 DK 4346847 T3 DK4346847 T3 DK 4346847T3 DK 22732150 T DK22732150 T DK 22732150T DK 4346847 T3 DK4346847 T3 DK 4346847T3
Authority
DK
Denmark
Prior art keywords
pluri
prevention
treatment
ionic complex
neurogenic inflammation
Prior art date
Application number
DK22732150.2T
Other languages
English (en)
Inventor
Wesepoel Philippe Van
Jean-François Plucker
Original Assignee
Olys Pharma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olys Pharma Srl filed Critical Olys Pharma Srl
Application granted granted Critical
Publication of DK4346847T3 publication Critical patent/DK4346847T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/06Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/14Alkali metal chlorides; Alkaline earth metal chlorides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/32Manganese; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/34Copper; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK22732150.2T 2021-06-04 2022-06-03 Pluri-ionisk kompleks til anvendelse i forebyggelse eller behandling af neurogen inflammation DK4346847T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE20215448A BE1029458B1 (fr) 2021-06-04 2021-06-04 Complexe pluri-ionique pour la prévention ou le traitement de l'inflammation neurogène
PCT/EP2022/065271 WO2022254042A1 (en) 2021-06-04 2022-06-03 Pluri-ionic complex for the prevention or treatment of neurogenic inflammation

Publications (1)

Publication Number Publication Date
DK4346847T3 true DK4346847T3 (da) 2025-10-20

Family

ID=76325316

Family Applications (1)

Application Number Title Priority Date Filing Date
DK22732150.2T DK4346847T3 (da) 2021-06-04 2022-06-03 Pluri-ionisk kompleks til anvendelse i forebyggelse eller behandling af neurogen inflammation

Country Status (10)

Country Link
US (1) US20240261323A1 (da)
EP (1) EP4346847B1 (da)
JP (1) JP2024520753A (da)
CN (1) CN117479948A (da)
BE (1) BE1029458B1 (da)
DK (1) DK4346847T3 (da)
ES (1) ES3047741T3 (da)
PL (1) PL4346847T3 (da)
PT (1) PT4346847T (da)
WO (1) WO2022254042A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1030588B1 (fr) * 2022-06-03 2024-01-08 Ynios Pharma Complexe pluri-ionique pour la prévention ou le traitement de l'inflammation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639625A (en) * 1967-07-13 1972-02-01 Lewis Sherwin Compositions containing lithium succinate
US5516534A (en) * 1993-11-26 1996-05-14 Rensselaer Polytechnic Institute Composition and method for reducing structural defects
US6572902B2 (en) * 2001-04-25 2003-06-03 Advanced H2O, Inc. Process for producing improved alkaline drinking water and the product produced thereby
CA2730009C (en) * 2007-07-12 2017-08-15 Whipbird Pain Relief Pty Ltd. Topical medicament
AU2008274908B2 (en) * 2008-07-11 2014-08-14 Whipbird Pain Relief Pty Ltd Topical medicament
HUE056696T2 (hu) * 2008-12-09 2022-03-28 Warburton Technology Ltd Nyomelemek
KR100943204B1 (ko) * 2009-07-14 2010-02-19 주식회사메자이텍 혈액순환 개선용 기능성 음용수 및 이의 제조방법
KR101326472B1 (ko) * 2011-11-28 2013-11-08 가톨릭대학교 산학협력단 광천수를 함유한 비강 세척용 조성물
CN108310287A (zh) * 2018-04-26 2018-07-24 深圳安济堂医药科技有限公司 治疗癌症的口服液及其制备方法
KR102187895B1 (ko) * 2019-03-12 2020-12-07 가톨릭대학교 산학협력단 대사성 질환의 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
BE1029458B1 (fr) 2023-01-09
EP4346847A1 (en) 2024-04-10
US20240261323A1 (en) 2024-08-08
EP4346847B1 (en) 2025-09-17
PL4346847T3 (pl) 2025-12-01
BE1029458A1 (fr) 2023-01-05
JP2024520753A (ja) 2024-05-24
PT4346847T (pt) 2025-10-23
ES3047741T3 (en) 2025-12-04
CN117479948A (zh) 2024-01-30
WO2022254042A1 (en) 2022-12-08

Similar Documents

Publication Publication Date Title
DK3860990T3 (da) Inhibitorer for YAP/TAZ-TEAD interaktion og disses anvendelse ved behandlingen af cancer
DK4014976T3 (da) Aprocitentan til anvendelse i behandlingen af hypertension og relaterede sygdomme i kombination med valsartan
DK3402499T3 (da) Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes
DK3713554T3 (da) Doseringsanvisninger for vidofludimus til behandling af kroniske inflammatoriske og/eller autoimmunsygdomme
DK3806898T3 (da) Gremlin-1-antagonist til anvendelse i behandling af cancer
DK4327866T3 (da) Mirikizumab ved behandling af ulcerøs kolitis
DK3972643T3 (da) Komplementsystemantagonister til anvendelse i fremgangsmåder til behandling af paraproteinemiske neuropatier
DK3962601T3 (da) 5-HT2A-agonister til anvendelse til behandling af depression
DK3982924T3 (da) Planteekstraktblanding til anvendelse ved forebyggelse og/eller behandling af kroniske inflammatoriske tarmsygdomme
DK3432899T3 (da) Anvendelse af probiotika ved behandling og/eller forebyggelse af psoriasis
DK3247352T3 (da) Cebranopadol til behandling af smerter hos individer med forringet lever- og/eller forringet nyrefunktion
DK3362449T3 (da) Sibirilin-derivater til anvendelse til at forebygge og/eller behandle lidelser associeret med cellulær nekroptose
MA49248A (fr) Inhibiteurs de fgfr2 utilisés dans le traitement du cholangiocarcinome
DK3570940T3 (da) Pridopidin til anvendelse i behandling af fragilt x-syndrom
DK4005570T3 (da) Pridopidin til anvendelse behandling af retts syndroe
DK3442547T3 (da) Lactobacillus reuteri MM4-1A til anvendelse i behandling eller forebyggelse af autismespektrumforstyrrelser
DK3522904T3 (da) Flydende sammensætning til anvendelse i behandlingen af gastroesophageal reflux
DK3592355T3 (da) KX2-391/KX-01 til anvendelse i behandling af aktinisk keratose
IL270978B (en) Grape skin for use in the treatment of dysbiosis
DK3866772T3 (da) 2,3,5-trimethyl-6-nonylcyclohexa-2,5-dien-1,4-dion til undertrykkelse og behandling af alpha-synucleinopathier, tauopathier og andre lidelser
DK3519411T3 (da) Heterocykliske forbindelser og deres anvendelse inden for forebyggelsen eller behandlingen af bakterieinfektioner
DK4419526T3 (da) Heterocykliske forbindelser til anvendelse i behandlingen af cancer
DK3506900T3 (da) Ampreloxetin til anvendelse i behandlingen af neurogen ortostatisk hypotension
DK3373922T3 (da) Sammensætninger og fremgangsmåder til anvendelse i behandlingen af homocystinuri
DK4346847T3 (da) Pluri-ionisk kompleks til anvendelse i forebyggelse eller behandling af neurogen inflammation